InterCure Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was ILS 45.230 million compared to ILS 11.185 million a year ago. Operating income was ILS 8.879 million compared to operating loss of ILS 847,000 a year ago. Net income was ILS 6.192 million compared to net loss of ILS 978,000 a year ago. Basic earnings per share from continuing operations was ILS 0.14 compared to basic loss per share from continuing operations of ILS 0.02 a year ago. Diluted earnings per share from continuing operations was ILS 0.12 compared to diluted loss per share from continuing operations of ILS 0.02 a year ago. For the half year, sales was ILS 78.281 million compared to ILS 15.444 million a year ago. Operating income was ILS 14.594 million compared to operating loss of ILS 48.231 million a year ago. Net income was ILS 9.405 million compared to net loss of ILS 48.187 million a year ago. Net income was ILS 9.405 million. Basic earnings per share from continuing operations was ILS 0.29 compared to ILS 2 a year ago. Diluted earnings per share from continuing operations was ILS 0.24 compared to ILS 2 a year ago.